Class I HDAC overexpression promotes temozolomide resistance in glioma cells by regulating RAD18 expression

Overexpression of histone deacetylases (HDACs) in cancer commonly causes resistance to genotoxic-based therapies. Here, we report on the novel mechanism whereby overexpressed class I HDACs increase the resistance of glioblastoma cells to the S(N)1 methylating agent temozolomide (TMZ). The chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanisch, Daniela, Krumm, Andrea, Diehl, Tamara, Stork, Carla M., Dejung, Mario, Butter, Falk, Kim, Ella, Brenner, Walburgis, Fritz, Gerhard, Hofmann, Thomas G., Roos, Wynand P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975953/
https://www.ncbi.nlm.nih.gov/pubmed/35365623
http://dx.doi.org/10.1038/s41419-022-04751-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975953/
https://www.ncbi.nlm.nih.gov/pubmed/35365623
http://dx.doi.org/10.1038/s41419-022-04751-7

Ejemplares similares